Related Experiment Videos
One Touch II hospital system for neonates: correlation with serum glucose values
Neonatal Network : NN
|March 1, 1996
Summary
The LifeScan One Touch II glucose monitor shows good agreement with lab tests for neonates. This neonatal mode is reliable for monitoring blood glucose levels in newborn infants.
Area of Science:
- Neonatal medicine
- Clinical chemistry
- Medical device technology
Background:
- Accurate blood glucose monitoring is critical for neonatal care.
- Point-of-care glucose monitoring systems offer potential benefits in neonatal intensive care units (NICUs).
Purpose of the Study:
- To evaluate the accuracy of the LifeScan One Touch II blood glucose monitoring system in neonates.
- To compare the system's results against standard laboratory serum glucose analysis.
Main Methods:
- A correlation study was performed using 327 blood samples from newborn infants in a Level III NICU.
- Paired results from the LifeScan One Touch II (neonatal mode) and laboratory serum glucose analysis were compared.
Main Results:
- A strong correlation (r value = .902) was observed between the One Touch II system and laboratory serum glucose values.
- The system demonstrated good agreement with standard values for neonates with serum glucose levels below 100 mg/dL (5.6 mmol/L).
Conclusions:
- The LifeScan One Touch II, when used in neonatal mode, provides reliable blood glucose measurements in neonates.
- The device is suitable for monitoring neonatal serum glucose levels, particularly for values under 100 mg/dL.